Company
Circadian Therapeutics
Circadian Therapeutics develops products that target serious diseases associated with circadian rhythm disruption.
- Business model
- B2B
- Legal name
- Circadian Therapeutics Limited
Record updated 28 September 2026
About
Founded in 2016 as a spin-out from Oxford University, our world-leading science is based on the understanding of the molecular control of circadian rhythms, enabling us to develop unique therapeutics to treat serious diseases associated with disruption of the body clock.
Products
- Web
- CT1500